Open research questions in Cutaneous Melanoma Detection and Management
586 gap statements mined from Cutaneous Melanoma Detection and Management papers in our 7.9M-paper local library, which holds 2,746 papers on the topic — drawn mostly from each paper's own stated research gap, future-work, challenge and limitation notes, and its abstract. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one.
Choosing where to publish on Cutaneous Melanoma Detection and Management? See the ranked Medicine journals.
What the literature leaves open
They highlight the need for further validation of the proposed thresholds.
Authors’ reply to “Plaque vulnerability or lesion geometry? Interpreting CT-derived translesional gradients” · 2026 · DOIDelays in the healthcare system can negatively impact patient care. The paper identifies the need for uniform and protocol-driven care to address these challenges.
The increase in melanoma incidence is not matched by an equivalent increase in publications on the topic. There is a need for innovative frameworks and practical examples of integrative oncology care.
Poor image quality can decrease diagnostic accuracy. Case difficulty can decrease diagnostic accuracy, particularly for cases rated 'hard' or 'very hard'. The need to balance sensitivity and specificity when using multiple teledermatologists, as increasing the number of assessors can increase sensitivity but decrease specificity.
Teledermoscopic triage of melanoma-suspicious skin lesions is safe: A retrospective comparative diagnostic accuracy study with multiple assessors · 2024 · DOICutaneous melanoma (CM) is highly invasive with limited prognostic tools, and the prognostic relevance of lactylation, a novel post-translational modification, remains unexplored.
A relative methylation ordering biomarker of lactylation-related genes predicts prognosis and therapeutic response in cutaneous melanoma · 2026 · DOIAccurate segmentation of skin lesions is of critical clinical importance for early melanoma diagnosis; however, the direct application of large foundation models like the Segment Anything Model (SAM) to medical images characterized by low contrast and fuzzy boundaries remains insufficient due to substantial domain gaps.
Comparative Analysis and Adaptation Strategies of Vision Foundation Models in Dermoscopic Image Segmentation · 2026 · DOIHowever, the impact of CPP implementation on melanoma stage distribution and outcomes has not been assessed.
Fast-track Cancer Patient Pathways and their impact on melanoma stage distribution and prognosis: A nationwide Danish cohort study · 2026 · DOIBecause of its unique molecular alterations, the applicability of findings from Western-based clinical trials to AM remains uncertain, leading to a lack of high-level evidence for this subtype.
Interleukin (IL)-4 is considered essential for Th2-polarisation in the TME; however, its source remains unknown.
Basophil‐Derived IL ‐4 Production and Its Potential Pro‐Tumoural Role in Th2‐Polarisation Within Sentinel Lymph Nodes of Primary Cutaneous Melanoma · 2025 · DOIFurther studies with larger sample sizes are warranted to validate these findings and explore the broader applicability of EVCM in clinical practice.
Precision at the Cutting Edge: Ex Vivo Confocal Microscopy for Perioperative Tumour Thickness Assessment in Melanoma · 2025 · DOIThe study addresses a range of skin disorders, including acne, vitiligo, hyperpigmentation, nail psoriasis, and SJS-TEN, focusing on aspects that remain underexplored in previous research.
Explainable AI for skin disease classification using gradient-weighted class activation mapping and transfer learning in digital health to identify contours · 2025 · DOILittle is known about the characteristics of PRAME expression in pediatric melanoma.
Characterization of PRAME immunohistochemistry reveals lower expression in pediatric melanoma compared to adult melanoma · 2024 · DOIHowever, the relationship between MetS, its individual components and melanoma metastasis remains unexplored.
Association Between Melanoma Metastasis and Metabolic Syndrome: A Cross‐Sectional Study in a Chinese Population · 2024 · DOIDespite this, we believe a reconsideration of the role of radical surgery is warranted given the increase in survival seen when combined with neoadjuvant immunotherapy.
However, exactly which nodal basins to examine has not been established, should it be focused on the positive sentinel node site or all basins indicated by the lymphoscintigraphy? This study aims to describe the patterns of recurrences in patients with trunk melanoma.
72235 - Pattern of regional recurrences in patients with trunk melanoma and implications for ultrasound follow-up · 2024 · DOIOptimal management remains unclear but surgical resection is considered the mainstay of treatment for this condition.
426 Nasopharyngeal Malignant Melanoma Masquerading in the Gallbladder: The Importance of Histological Assessment · 2024 · DOIAs effective melanoma treatments have become available, utilizing isolated limb perfusion (ILP) to treat unresectable melanoma limited to the limb has decreased.
Association of Pretreatment Tumour Microenvironment and Treatment Outcome in Patients With Locally Advanced Melanoma Treated With Isolated Limb Perfusion · 2025 · DOIMany factors concerning melanoma mortality are poorly understood, posing an obstacle to optimal care.
Causes of death and patterns of metastatic disease at the end of life for patients with advanced melanoma in the immunotherapy era · 2024 · DOIThe study used data from a large-scale survey, but the analysis was limited to participants with complete data. The study did not account for all potential confounding variables.
Machine learning-based association analysis of triglyceride-glucose index with melanoma prevalence and all-cause mortality: insights from cross-sectional NHANES 1999–2018 data and an external hospital-based dataset · 2026 · DOIThe study utilized a relatively small sample size of 72 patients, - The patient enrollment period was limited to February 2024 to May 2026, - Internal validation was critical due to the large number of candidate variables relative to sample…
Melanoma Intelligence: Explainable AI Reveals Histopathologic Aggressiveness as the Dominant Axis of Lymph-Node Metastasis · 2026 · DOIInvestigating emerging non-invasive techniques in melanoma diagnosis, staging, and monitoring, - Incorporating sensing technologies and spectroscopy methods not commonly considered…
Further investigation of non-CDKN2A germline variants - Exploration of the genetic alterations associated with melanoma - Study of the clinical phenotype observed in families with CDK4…
Future teledermoscopy guidelines should encompass safety procedures and protocols for disagreement between assessors, - Further research on the application of TDT in different populations…
Teledermoscopic triage of melanoma-suspicious skin lesions is safe: A retrospective comparative diagnostic accuracy study with multiple assessors · 2024 · DOIEven though matching reduced the bias and enhanced the validity of these findings, the major limitations lie in the retrospective nature and sample size.
Further investigation of HSI as a complementary imaging modality for early melanoma detection. Development of computer-aided diagnostic systems for melanoma detection using HSI.
Minimizing the False Negative Rate in Convolutional Neural Network-Based Melanoma Classification Using Hyperspectral Data to Reduce Misdiagnosis · 2026 · DOI
Most-cited papers in Cutaneous Melanoma Detection and Management
- Dermatologist-level classification of skin cancer with deep neural networks · Nature · 2017 · 12,434 citations
- Distinct Sets of Genetic Alterations in Melanoma · New England Journal of Medicine · 2005 · 2,329 citations
- Melanoma · The Lancet · 2018 · 1,374 citations
- Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040 · JAMA Dermatology · 2022 · 1,330 citations
- Human–computer collaboration for skin cancer recognition · Nature Medicine · 2020 · 997 citations
- A deep learning system for differential diagnosis of skin diseases · Nature Medicine · 2020 · 776 citations
- Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study · The Lancet · 2024 · 729 citations
- Classification of Skin Disease Using Deep Learning Neural Networks with MobileNet V2 and LSTM · Sensors · 2021 · 703 citations
- FAT-Net: Feature adaptive transformers for automated skin lesion segmentation · Medical Image Analysis · 2021 · 570 citations
- Skin Cancer Detection: A Review Using Deep Learning Techniques · International Journal of Environmental Research and Public Health · 2021 · 545 citations
Most recent work
- Emerging biomarkers in melanoma: Bridging molecular discovery and precision oncology · Cancer Letters · 2026
- Prospective Evidence on Artificial Intelligence−Assisted Melanoma Diagnostics · JAMA Dermatology · 2026
- Explainable AI-driven hybrid deep learning framework for accurate skin cancer diagnosis · Digital Health · 2026
- Exploring the challenge and value of deep learning in automated skin disease diagnosis · Biomedical Signal Processing and Control · 2026
- Toripalimab vs Dacarbazine as First-Line Therapy for Advanced Melanoma of Acral Subtype · JAMA Oncology · 2026
- Ochre fluorescence under ultraviolet-induced fluorescence dermatoscopy is a strong clue to melanoma: Results of an international retrospective cross-sectional study · Journal of the American Academy of Dermatology · 2026
- Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial · Nature Medicine · 2026
- Enhancing skin cancer detection using attention-based CapsNet with transfer learning from pre-trained CNN · Biomedical Signal Processing and Control · 2026
- Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial · Nature Cancer · 2026
- Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Resected Melanoma: 5-Year Update of the Randomized Phase IIb KEYNOTE-942 Study · Journal of Clinical Oncology · 2026
Find a gap in your own Cutaneous Melanoma Detection and Management sub-topic
This page shows what the Cutaneous Melanoma Detection and Management literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 7.9M-paper local library and writes the gaps from its rows.
Open the Research Gap Finder →